For research use only. Not for therapeutic Use.
HS-276(Cat No.:I043517)is a novel compound under investigation for its potential therapeutic applications, particularly in the treatment of cancer. It functions as a selective inhibitor of specific protein kinases involved in cell signaling pathways that regulate growth, survival, and metastasis of cancer cells. By targeting these kinases, HS-276 aims to block the mechanisms that allow tumors to grow uncontrollably and resist traditional treatments. Early studies suggest that HS-276 may enhance the effectiveness of existing cancer therapies, offering a promising option for patients with certain types of tumors that are resistant to conventional treatments.
CAS Number | 2767422-72-8 |
Synonyms | 3-N-[6-(piperidin-1-ylmethyl)-1-propylbenzimidazol-2-yl]benzene-1,3-dicarboxamide |
Molecular Formula | C24H29N5O2 |
Purity | ≥95% |
IUPAC Name | 3-N-[6-(piperidin-1-ylmethyl)-1-propylbenzimidazol-2-yl]benzene-1,3-dicarboxamide |
InChI | InChI=1S/C24H29N5O2/c1-2-11-29-21-14-17(16-28-12-4-3-5-13-28)9-10-20(21)26-24(29)27-23(31)19-8-6-7-18(15-19)22(25)30/h6-10,14-15H,2-5,11-13,16H2,1H3,(H2,25,30)(H,26,27,31) |
InChIKey | NPEMHKSMWPZEOV-UHFFFAOYSA-N |
SMILES | CCCN1C2=C(C=CC(=C2)CN3CCCCC3)N=C1NC(=O)C4=CC=CC(=C4)C(=O)N |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |